Glucose monitoring for diabetes patients on peritoneal dialysis
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether using a continuous glucose monitor (a small sensor that checks blood sugar levels throughout the day) can help improve diabetes control in people who are on peritoneal dialysis (a type of kidney dialysis done at home). It aims to see if this technology leads to better health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 1 or type 2 diabetes for at least 3 months.
- You have advanced kidney disease (stage 5) and have been on peritoneal dialysis for at least 3 months, or you are planning to start it within the next 3 months.
- You are willing to wear a glucose sensor and follow the study procedures, including not swimming during the measurement period.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not plan to switch to hemodialysis or have a kidney transplant in the next 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This study tests a new sensor system that can predict fluid overload (congestion) in people on peritoneal dialysis. It may help you and your care team spot problems early so you can avoid hospital visits.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests whether using a real-time continuous glucose monitor (a device that tracks your blood sugar continuously) helps improve blood sugar control in people with type 2 diabetes who also have chronic kidney disease (stages 3 and 4). If you qualify, you may get better insight into your glucose patterns, which could help you manage your diabetes more effectively.
Hear when a new Continuous Glucose Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.